Outpace Bio (Series B)

Funding Details
Awarder
RSS - www.geekwire.com
Date Award
August 01, 2024
Vertical
Biotech
Funding URL
View Funding Page

Company Info
Founding Year
2021
Traction
Outpace has raised $200 million to date and is preparing to test its treatment in a clinical setting.
Organizations Involved
Fred Hutchinson Cancer Center
Founders
Marc Lajoie, Scott Boyken
Company Description
Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.
Market
Cancer Therapies
Location
Seattle, WA, US
Coinvestors
RA Capital Management, Qatar Investment Authority, Surveyor Capital, Sheatree Capital, Black Opal Ventures, Alexandria Venture Investments, ARTIS Ventures, Playground Global, Bristol Myers Squibb, Abstract Ventures, Civilization Ventures, Mubadala Capital, Breton Capital Ventures, WRF Capital, Sahsen Ventures

Links
Back to Home Back to Biotech Deals View Funding Announcement